Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Seeking to best an earlier deal, Endo International has offered to acquire Salix Pharmaceuticals for $175.00 per share in cash and stock. Last month, Salix, a specialist in gastrointestinal treatments, agreed to be acquired by Valeant Pharmaceuticals for $158.00 per share, or about $14 billion including debt. Valeant says it stands by its all-cash deal, “which delivers immediate and certain value to Salix shareholders.” Salix says it will review the new offer.
This article has been sent to the following recipient: